Which of the following is least useful in Rx of “Overactive bladder”?
**Core Concept**
The management of overactive bladder (OAB) involves a combination of lifestyle modifications, behavioral therapies, and pharmacological interventions. **Antimuscarinics** and **beta-3 adrenergic agonists** are commonly used to reduce symptoms of urgency, frequency, and urge incontinence.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's discuss the general approach to OAB treatment. **Antimuscarinics**, such as oxybutynin, work by blocking **muscarinic receptors** in the bladder, thereby reducing involuntary contractions. **Beta-3 adrenergic agonists**, like mirabegron, increase bladder capacity by relaxing the detrusor muscle during the storage phase.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, typically, **antimuscarinics** are useful in OAB treatment.
**Option B:** Similarly, **beta-3 adrenergic agonists** are beneficial for OAB symptoms.
**Option C:** and **Option D:** would depend on the specific treatments listed, but generally, options that are not **antimuscarinics** or **beta-3 adrenergic agonists** might be less useful or have different primary indications.
**Clinical Pearl / High-Yield Fact**
A key point in managing OAB is identifying and managing underlying causes or contributing factors, such as urinary tract infections or neurological disorders.
**Correct Answer:** Not provided in the query.